MedTrace Logo

The Effect of Asthma Education Given by Taking Health Literacy Into Account

NCT05618665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2022-11-16

No results posted yet for this study

Summary

The aim of this randomized controlled trial was to examine the effect of education given to asthmatic children and their parents by taking health literacy into account on disease self-management.

The study was conducted with 88 children and their parents between October 2018 and July 2019. While education and booklets were given to both children and parents in intervention group 1, only the children were given the education and the booklets in intervention group 2. There was no intervention applied for the control group. Post-test was performed 3 weeks after the education and then follow-ups were carried out in the next three months over the phone.

Conditions

  • Asthma in Children
  • Health Literacy
  • Child Health
  • Asthma Management
  • Nursing

Interventions

OTHER

Asthma Education

Asthma education about asthma disease, its symptoms, diagnosis, treatment, risk factors, use of medication, use of medication apparatus, vaccination treatment, follow-up of the asthmatic child, precautions to be taken in prevention, what to do during an attack, what to do for adaptation to the disease and things to do in school life.

OTHER

Delivery of booklets

The booklets, prepared by the researchers, included information about the content of the education.

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Ayla BAYIK TEMEL, Prof. · Department of Nursing, Ege University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-07-01
Completion
2019-07-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618665 on ClinicalTrials.gov